Agilent Technologies Inc. has announced a strategic partnership with PathAI to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.

Owlstone Medical has announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care devices and support resources for a range of conditions.

Waters Corporation has unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical diagnostic applications.

A new study has shown graphene-based biosensors could play a major role in detecting Interleukin-10 (IL-10), an important inflammation regulator, at significantly lower levels than previous point-of-care measurements.

Aptamer Group plc announces that it has developed a new reagent, Optimer®-Fc, for use in automated immunohistochemistry (IHC) workflows.

OGT announces that IVDR certification has been granted for eight CytoCell® fluorescence in situ hybridization (FISH) probes important for patient management in hematological cancers and prenatal conditions.

Personalis, Inc. has announced it will continue its collaboration with AstraZeneca to explore ultra-sensitive molecular residual disease measurement, including clinically relevant and personalized variant tracking, for clinical research and drug development.

Co-funded by Innovate UK, Aseptika is collaborating with the University of Birmingham, University of York and the National Audit of Cardiac Rehabilitation to study the impact of a hybrid delivery of cardiac rehabilitation.

Beckman Coulter Diagnostics and MeMed have announced a strategic partnership to jointly develop and commercialize a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analysers.

Abingdon Health plc announces the signing of a new distribution agreement with Salignostics for the launch of the first saliva-based pregnancy test in the UK and Ireland.